Niacin CRT 500 mg (60 tabs) by Designs for Health

Niacin CRT is a unique wax-matrix tablet which utilizes the latest controlled release technology (CRT). This technology delivers niacin in a continuous, controlled rate over a 6-8 hour period, throughout the tablet’s transit time in the bowel. Flushing sometimes happens with time-release niacin, as there can be fairly large surges of niacin released intermittently. However, flushing is less likely with controlled release niacin. This product is available in 500 mg and 750 mg tablets, with the higher dosage of 750 mg being more convenient for those with a greater need for lipid management. Recommended Use: As a dietary supplement, take one tablet per day with a meal, or as directed by your health care practitioner.

60 tablets.

*This product is not intended to diagnose, treat, or cure any illness or disease. The content and recommendations contained on this website have not been reviewed by the U.S. Food and Drug Administration (FDA) and are solely the opinion of the authors. Content contained on this website is not a substitute for professional medical advice, diagnosis, or treatment. Never increase, reduce or discontinue any medication or treatment without first consulting your doctor.*

Disclaimer††An IPSOS 2023 survey among US functional medicine practitioners, in an average month, Designs for Health is their personally most trusted practitioner supplement brand, meaning a brand that is sold by healthcare practitioners in their office.††An Ipsos 2023 study among a random sample of 160 functional medicine practitioners including Doctor’s of Osteopathic Medicine, Pharmacists, Acupuncturists, Athletic Trainers, Personal Trainers, Fitness Trainer/Coaches, Chiropractors, Integrative Medicine Specialists, Naturopathic Doctor, Homeopaths, Medical Doctors, Physical Therapists, Nurse Practitioner/Physician Assistants, Registered Nurses, Nutritionists, Massage Therapists, Occupational Therapists and Dieticians that are aware of Designs for Health and recommend supplements to their patients.**